Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ion channels and epilepsy.

H Lerche1, K Jurkat-Rott, F Lehmann-Horn

  • 1Department of Applied Physiology, Univeristy of Ulm, Germany.

American Journal of Medical Genetics
|October 2, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and genetic spectrum of SCN2A-associated episodic ataxia.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2019
Same author

Effects of S906T polymorphism on the severity of a novel borderline mutation I692M in Na<sub>v</sub> 1.4 cause periodic paralysis.

Clinical genetics·2016
Same author

Transcutaneous Vagus Nerve Stimulation (tVNS) for Treatment of Drug-Resistant Epilepsy: A Randomized, Double-Blind Clinical Trial (cMPsE02).

Brain stimulation·2016
Same author

Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia.

Journal of neurology·2015
Same author

Contractile elements in muscular fascial tissue - implications for in-vitro contracture testing for malignant hyperthermia.

Anaesthesia·2014
Same author

Characterization of hyperkalemic periodic paralysis: a survey of genetically diagnosed individuals.

Journal of neurology·2013
Same journal

Abstracts for the Xth World Congress of Psychiatric Genetics. Brussels, Belgium, 9-13 October 2002.

American journal of medical genetics·2003
Same journal

Defects of blastogenesis.

American journal of medical genetics·2002
Same journal

Malformations of the craniofacial region: evolutionary, embryonic, genetic, and clinical perspectives.

American journal of medical genetics·2002
Same journal

Limb anomalies: Developmental and evolutionary aspects.

American journal of medical genetics·2002
Same journal

Molecular etiology of gut malformations and diseases.

American journal of medical genetics·2002
Same journal

Status of the human malformation map: 2002.

American journal of medical genetics·2002
See all related articles

Mutations in ion channel genes cause channelopathies, leading to inherited disorders like epilepsy. Studying these rare diseases offers insights into disturbed excitability and aids in developing new therapies, such as retigabine for epilepsy.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Ion channels regulate excitability in the central nervous system and muscle tissues.
  • Mutations in genes encoding ion channels cause inherited 'channelopathies,' resulting in tissue hyperexcitability or hypoexcitability.

Purpose of the Study:

  • To explore the role of ion channel mutations in various inherited epileptic syndromes.
  • To highlight channelopathies as models for studying the pathophysiology of disturbed excitability.
  • To underscore the potential for developing novel therapeutic strategies based on genetic and electrophysiologic findings.

Main Methods:

  • Genetic analysis of patients with channelopathies.
  • Electrophysiologic studies to understand channel function.

Related Experiment Videos

  • Review of existing literature on epilepsy and channelopathies.

    • Main Results:

    • Identified specific gene mutations (CHRNA4, CHRNB2, KCNQ2, KCNQ3, SCN1B, SCN1A, GABRG2, KCNA1) linked to epilepsy syndromes like autosomal dominant nocturnal frontal lobe epilepsy and benign familial neonatal convulsions.
    • Demonstrated that channelopathies provide valuable models for molecular studies of disturbed excitability.
    • Showcased retigabine as a successful therapeutic strategy activating neuronal KCNQ potassium channels for epilepsy.

    Conclusions:

    • Ion channel mutations are a significant cause of inherited epilepsy and other neurological disorders.
    • Channelopathies serve as crucial models for understanding the molecular basis of neurological hyperexcitability.
    • Targeting specific ion channels, like KCNQ potassium channels, offers promising avenues for novel antiepileptic drug development.